73 related articles for article (PubMed ID: 21325218)
1. Pillars article: long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature. 1996. 381: 434-438. 1996.
Larsen CP; Elwood ET; Alexander DZ; Ritchie SC; Hendrix R; Tucker-Burden C; Cho HR; Aruffo A; Hollenbaugh D; Linsley PS; Winn KJ; Pearson TC
J Immunol; 2011 Mar; 186(5):2693-7. PubMed ID: 21325218
[No Abstract] [Full Text] [Related]
2. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways.
Larsen CP; Elwood ET; Alexander DZ; Ritchie SC; Hendrix R; Tucker-Burden C; Cho HR; Aruffo A; Hollenbaugh D; Linsley PS; Winn KJ; Pearson TC
Nature; 1996 May; 381(6581):434-8. PubMed ID: 8632801
[TBL] [Abstract][Full Text] [Related]
3. IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways.
Konieczny BT; Dai Z; Elwood ET; Saleem S; Linsley PS; Baddoura FK; Larsen CP; Pearson TC; Lakkis FG
J Immunol; 1998 Mar; 160(5):2059-64. PubMed ID: 9498741
[TBL] [Abstract][Full Text] [Related]
4. Anergic cells induced by the blockade of CD40-CD154 and CD28-B7 costimulatory pathways act as potent immunoregulatory cells in vitro and vivo.
Cai Y; Zhou PJ; Tang XD
Chin Med J (Engl); 2004 Aug; 117(8):1178-83. PubMed ID: 15361291
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of allorecognition and skin graft rejection in CD28 and CD40 ligand double-deficient mice.
Habiro K; Kotani M; Omoto K; Kobayashi S; Tanabe K; Shimmura H; Suzuki K; Hayashi T; Toma H; Abe R
Transplantation; 2003 Sep; 76(5):854-8. PubMed ID: 14501867
[TBL] [Abstract][Full Text] [Related]
6. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
Cai Y; Tang XD; Zhou PJ
Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
[TBL] [Abstract][Full Text] [Related]
7. Specific acceptance of cardiac allografts after treatment with antibodies to CD80 and CD86 in mice.
Bashuda H; Seino K; Kano M; Sato K; Azuma M; Yagita H; Okumura K
Transplant Proc; 1996 Apr; 28(2):1039-41. PubMed ID: 8623220
[No Abstract] [Full Text] [Related]
8. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
[TBL] [Abstract][Full Text] [Related]
9. Costimulation blockade of CD40 and CD28 pathways in limb transplantation.
Tung TH; Mackinnon SE; Mohanakumar T
Transplant Proc; 2008 Dec; 40(10):3723-4. PubMed ID: 19100474
[TBL] [Abstract][Full Text] [Related]
10. Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection.
Trambley J; Bingaman AW; Lin A; Elwood ET; Waitze SY; Ha J; Durham MM; Corbascio M; Cowan SR; Pearson TC; Larsen CP
J Clin Invest; 1999 Dec; 104(12):1715-22. PubMed ID: 10606625
[TBL] [Abstract][Full Text] [Related]
11. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
Hüser N; Tertilt C; Gerauer K; Maier S; Traeger T; Assfalg V; Reiter R; Heidecke CD; Pfeffer K
Eur J Immunol; 2005 Jan; 35(1):128-38. PubMed ID: 15593118
[TBL] [Abstract][Full Text] [Related]
12. Interaction between CD4 and CD8 T cells determines graft outcome in monoclonal antibody-treated mice.
Hamano K; Morris PJ; Wood KJ
Transplant Proc; 1993 Feb; 25(1 Pt 1):792-3. PubMed ID: 8438483
[No Abstract] [Full Text] [Related]
13. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
[TBL] [Abstract][Full Text] [Related]
14. Gamma delta TCR+ hybridomas derived from mice preimmunized via the portal vein adoptively transfer increased skin allograft survival in vivo.
Gorczynski RM; Cohen Z; Leung Y; Chen Z
J Immunol; 1996 Jul; 157(2):574-81. PubMed ID: 8752904
[TBL] [Abstract][Full Text] [Related]
15. Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival.
Cho HR; Kwon B; Yagita H; La S; Lee EA; Kim JE; Akiba H; Kim J; Suh JH; Vinay DS; Ju SA; Kim BS; Mittler RS; Okumura K; Kwon BS
Transpl Int; 2004 Aug; 17(7):351-61. PubMed ID: 15349720
[TBL] [Abstract][Full Text] [Related]
16. Blockade of CD27/CD70 pathway to reduce the generation of memory T cells and markedly prolong the survival of heart allografts in presensitized mice.
Dai H; Chen J; Shao W; Wang F; Xu S; Peng Y; Lin Y; Xia J; Ekberg H; Wang X; Qi Z
Transpl Immunol; 2011 May; 24(4):195-202. PubMed ID: 21396447
[TBL] [Abstract][Full Text] [Related]
17. Induction of indefinite survival of fully allogeneic cardiac grafts and generation of regulatory cells by intratracheal delivery of alloantigens under blockade of the CD40 pathway.
Uchida N; Shirasugi N; Akiyama Y; Matsumoto K; Shimazu M; Kitajima M; Hamano K; Aramaki O; Ikeda Y; Niimi M
Transplantation; 2003 Mar; 75(6):878-84. PubMed ID: 12660518
[TBL] [Abstract][Full Text] [Related]
18. Heart, but not skin, allografts from donors lacking Flt3 ligand exhibit markedly prolonged survival time.
Wang Z; Castellaneta A; De Creus A; Shufesky WJ; Morelli AE; Thomson AW
J Immunol; 2004 May; 172(10):5924-30. PubMed ID: 15128773
[TBL] [Abstract][Full Text] [Related]
19. In vivo visualization of cardiac allograft rejection and trafficking passenger leukocytes using bioluminescence imaging.
Tanaka M; Swijnenburg RJ; Gunawan F; Cao YA; Yang Y; Caffarelli AD; de Bruin JL; Contag CH; Robbins RC
Circulation; 2005 Aug; 112(9 Suppl):I105-10. PubMed ID: 16159800
[TBL] [Abstract][Full Text] [Related]
20. Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus.
DeBenedette MA; Wen T; Bachmann MF; Ohashi PS; Barber BH; Stocking KL; Peschon JJ; Watts TH
J Immunol; 1999 Nov; 163(9):4833-41. PubMed ID: 10528184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]